/news

Coherus (CHRS) Climbs in Active Trading for June 23

Equities Staff  |

Shares of Coherus Biosciences Inc (NASDAQ:CHRS) traded 10.13% higher on June 23 to close at $7.39.

1,745,406 were traded today. Their current average 30 day volume is 1,092,487 shares.

Coherus is down 57.96% year-to-date in 2022.

The company is set to release earnings on 2022-08-04.

For technical charts, analysis, and more on Coherus visit the company profile.

About Coherus Biosciences Inc

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients' lives and to deliver significant savings to the health care system.

To get more information on Coherus Biosciences Inc and to follow the company's latest updates, you can visit the company's profile page here: Coherus Biosciences Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Will Mining Stocks Fall Further?
3 Reasons To Be Optimistic About the Global Shipping Industry
The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks



Market Movers

Sponsored Financial Content